Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ginkgo Bioworks Holdings (DNA)
NYSE:DNA
Holding DNA?
Track your performance easily
DNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.29 - $98.60
Previous Close$8.15
Volume1.38M
Average Volume (3M)1.51M
Market Cap
$1.41B
Enterprise Value$1.13B
Total Cash (Recent Filing)$730.37M
Total Debt (Recent Filing)$452.26M
Price to Earnings (P/E)―
Beta2.18
Next Earnings
Nov 11, 2024EPS Estimate
-$2.74Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-18.03
Shares Outstanding55,575,385
10 Day Avg. Volume1,854,919
30 Day Avg. Volume1,505,808
Standard Deviation0.22
R-Squared0.10
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)0.70
Price to Sales (P/S)2.50
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.12
Enterprise Value/Gross Profit5.51
Enterprise Value/Ebitda-1.46
Forecast
1Y Price Target
$13.56Price Target Upside66.38% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering4
Ginkgo Bioworks Holdings News
Bulls Say, Bears Say
Bulls Say
Financial Performance2Q revenue of $56M came in above expectations.
MilestonesDNA recognized a major technical milestone for a previously announced large biopharma customer.
Program Expansion18 new programs were added in the quarter, bringing the total to 140 active programs across 82 customers.
Bears Say
Financial PerformanceHigher expenses in the quarter led to an adj. EBITDA loss of $(99)mn vs. BofAe/Street of $(68)/(78)mn.
Sales And ProfitabilityVisibility into both sales trends and profitability are still severely limited, with no clear resolution in sight.
Stock PerformanceGinkgo completes 1-for-40 reverse stock split, we update our PT for the split.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DNA FAQ
What was Ginkgo Bioworks Holdings’s price range in the past 12 months?
Ginkgo Bioworks Holdings lowest stock price was $7.29 and its highest was $98.60 in the past 12 months.
What is Ginkgo Bioworks Holdings’s market cap?
Currently, no data Available
When is Ginkgo Bioworks Holdings’s upcoming earnings report date?
Ginkgo Bioworks Holdings’s upcoming earnings report date is Nov 11, 2024 which is in 79 days.
How were Ginkgo Bioworks Holdings’s earnings last quarter?
Ginkgo Bioworks Holdings released its earnings results on Aug 08, 2024. The company reported -$4.4 earnings per share for the quarter, missing the consensus estimate of -$3.098 by -$1.302.
Is Ginkgo Bioworks Holdings overvalued?
According to Wall Street analysts Ginkgo Bioworks Holdings’s price is currently Undervalued.
Does Ginkgo Bioworks Holdings pay dividends?
Ginkgo Bioworks Holdings does not currently pay dividends.
What is Ginkgo Bioworks Holdings’s EPS estimate?
Ginkgo Bioworks Holdings’s EPS estimate is -$2.74.
How many shares outstanding does Ginkgo Bioworks Holdings have?
Ginkgo Bioworks Holdings has 43,103,012 shares outstanding.
What happened to Ginkgo Bioworks Holdings’s price movement after its last earnings report?
Ginkgo Bioworks Holdings reported an EPS of -$4.4 in its last earnings report, missing expectations of -$3.098. Following the earnings report the stock price went down -5.424%.
Which hedge fund is a major shareholder of Ginkgo Bioworks Holdings?
Among the largest hedge funds holding Ginkgo Bioworks Holdings’s share is Viking Global Investors LP. It holds Ginkgo Bioworks Holdings’s shares valued at 48M.
---
Ginkgo Bioworks Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$13.56 (66.38% Upside)
$13.56 (66.38% Upside)
Blogger Sentiment
Bullish
DNA Sentiment 65%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 4.1M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 4.0%
Last 30 Days ▼ 4.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-88.61%
12-Months-Change
Fundamentals
Return on Equity
-76.83%
Trailing 12-Months
Asset Growth
-29.09%
Trailing 12-Months
Company Description
Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings (NYSE:DNA) is a biotechnology company that offers a platform for cell programming that enables the biological production of various products across the food, pharmaceutical, and fragrance industry. Its platform provides equipment, software, robotic automation, and tools to support genetic engineering, analytics, and fermentation.
---
DNA Company Deck
---
DNA Earnings Call
Q2 2024
0:00 / 0:00
---
DNA Revenue Breakdown
57.08% Cell Engineering
42.92% Biosecurity
---
DNA Stock 12 Month Forecast
Average Price Target
$13.56
▲(66.38% Upside)
Technical Analysis
Best Analysts Covering DNA
1 Year
1 Year Success Rate
4/15 ratings generated profit
1 Year Average Return
-18.68%
reiterated a sell rating 3 days ago
Copying Mark Massaro's trades and holding each position for 1 Year would result in 26.67% of your transactions generating a profit, with an average return of -18.68% per trade.
---